Assignee
OSI PHARM INC
US·77 granted patents·11 pending applications·1,321 citations·filing 1992–2011
Top patents by PatentIndex Score
88 records- 0199US7534797B26,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2005·Granted May 19, 2009·100 cites·9 claims
- 0295US7700594B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2006·Granted Apr 20, 2010·38 cites·6 claims
- 0395US6680324B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 20, 2004·68 cites·37 claims
- 0495US6680322B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 20, 2004·67 cites·37 claims
- 0594US6900221B1Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereofOSI PHARM INC·Filed 2000·Granted May 31, 2005·100 cites·79 claims
- 0694US6165712AMethods of transcriptionally modulating expression of viral genes and genes useful for production of proteinsOSI PHARM INC·Filed 1995·Granted Dec 26, 2000·120 cites·23 claims
- 0792US7651687B2Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitorsOSI PHARM INC·Filed 2007·Granted Jan 26, 2010·33 cites·28 claims
- 0892US7485658B2N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Feb 3, 2009·39 cites·5 claims
- 0992US7465726B2Substituted pyrrolo[2.3-B]pyridinesOSI PHARM INC·Filed 2005·Granted Dec 16, 2008·35 cites·14 claims
- 1092US6916804B2Pyrimidine A2b selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2002·Granted Jul 12, 2005·45 cites·22 claims
- 1191US7923555B2Fused bicyclic mTor inhibitorsOSI PHARM INC·Filed 2008·Granted Apr 12, 2011·15 cites·2 claims
- 1291US7087613B2Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochlorideOSI PHARM INC·Filed 2004·Granted Aug 8, 2006·47 cites·14 claims
- 1389US7820662B26,6-bicyclic ring substituted heterobicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2008·Granted Oct 26, 2010·12 cites·19 claims
- 1489US7648987B2Bicyclic protein kinase inhibitorsOSI PHARM INC·Filed 2006·Granted Jan 19, 2010·17 cites·8 claims
- 1589US6800633B2Pyrrolo[2,3d]pyrimidine compositions and their useOSI PHARM INC·Filed 2000·Granted Oct 5, 2004·29 cites·16 claims
- 1689US6673802B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 6, 2004·26 cites·16 claims
- 1788US7943767B2Fused bicyclic mTOR inhibitorsOSI PHARM INC·Filed 2009·Granted May 17, 2011·9 cites·14 claims
- 1888US7504407B2Compounds specific to adenosine A1 and A3 receptors and uses thereofOSI PHARM INC·Filed 2002·Granted Mar 17, 2009·29 cites·12 claims
- 1988US7459554B2Imidazopyrazine tyrosine kinase inhibitorsOSI PHARM INC·Filed 2004·Granted Dec 2, 2008·45 cites·68 claims
- 2087US7419995B2N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole libraryOSI PHARM INC·Filed 2005·Granted Sep 2, 2008·8 cites·16 claims
- 2186US7939272B2Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitorsOSI PHARM INC·Filed 2008·Granted May 10, 2011·11 cites·10 claims
- 2286US7659274B2Unsaturated mTOR inhibitorsOSI PHARM INC·Filed 2007·Granted Feb 9, 2010·9 cites·3 claims
- 2386US6664252B24-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Dec 16, 2003·28 cites·34 claims
- 2485US7405210B2Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylaseOSI PHARM INC·Filed 2004·Granted Jul 29, 2008·18 cites·20 claims
- 2585US7160890B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 9, 2007·16 cites·46 claims
- 2685US6136779AMethods of specifically transcriptionally modulating the expression of gene of interestOSI PHARM INC·Filed 1997·Granted Oct 24, 2000·48 cites·40 claims
- 2783US7429574B24-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their useOSI PHARM INC·Filed 2004·Granted Sep 30, 2008·14 cites·8 claims
- 2882US7741324B2Imidazotriazines as protein kinase inhibitorsOSI PHARM INC·Filed 2005·Granted Jun 22, 2010·6 cites·12 claims
- 2982US7101893B2(2-Carboxamido)(3-amino)thiophene compoundsOSI PHARM INC·Filed 2005·Granted Sep 5, 2006·4 cites·2 claims
- 3081US7951549B2Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formationOSI PHARM INC·Filed 2009·Granted May 31, 2011·9 cites·93 claims
- 3181US6878716B1Compounds specific to adenosine A1 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Apr 12, 2005·27 cites·35 claims
- 3280US6699894B1Methods for treatment of inflammatory bowel diseaseOSI PHARM INC·Filed 2002·Granted Mar 2, 2004·13 cites·2 claims
- 3378US7115647B2Method of inhibiting neoplastic cells with indole derivativesOSI PHARM INC·Filed 2002·Granted Oct 3, 2006·6 cites·3 claims
- 3477US7816325B2Secondary binding site of dipeptidyl peptidase IV (DP IV)OSI PHARM INC·Filed 2006·Granted Oct 19, 2010·1 cites·18 claims
- 3576US7501407B2Pyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2004·Granted Mar 10, 2009·8 cites·7 claims
- 3676US7144711B2AGS proteins and nucleic acid molecules and uses thereforOSI PHARM INC·Filed 2004·Granted Dec 5, 2006·5 cites·15 claims
- 3775US6869944B2Method for treating a patient with neoplasia by treatment with a platinum coordination complexOSI PHARM INC·Filed 2002·Granted Mar 22, 2005·3 cites·3 claims
- 3875US6203976B1Methods of preparing compositions comprising chemicals capable of transcriptional modulationOSI PHARM INC·Filed 1994·Granted Mar 20, 2001·31 cites·26 claims
- 3974US7521448B2N-substituted benzimidazolyl c-Kit inhibitorsOSI PHARM INC·Filed 2004·Granted Apr 21, 2009·9 cites·6 claims
- 4073US7645754B2Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2007·Granted Jan 12, 2010·1 cites·10 claims
- 4173US7598252B2Compounds specific to adenosine A, receptors and uses thereofOSI PHARM INC·Filed 2003·Granted Oct 6, 2009·4 cites·6 claims
- 4273US7566721B2Substituted thienol[2,3-d]pyrimidines as kinase inhibitorsOSI PHARM INC·Filed 2006·Granted Jul 28, 2009·3 cites·11 claims
- 4373US6706721B1N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 1999·Granted Mar 16, 2004·13 cites·12 claims
- 4472US7388012B2(Hydrazido)(amino)thiophene compoundsOSI PHARM INC·Filed 2005·Granted Jun 17, 2008·1 cites·14 claims
- 4570US7521456B2N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 2003·Granted Apr 21, 2009·3 cites·13 claims
- 4669US6686366B1Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Feb 3, 2004·32 cites·50 claims
- 4767US7662844B2Naphthylene derivatives as cytochrome P450 inhibitorsOSI PHARM INC·Filed 2004·Granted Feb 16, 2010·6 cites·33 claims
- 4867US7064122B2Pancreatic lipase inhibitor compounds, their synthesis and useOSI PHARM INC·Filed 2002·Granted Jun 20, 2006·3 cites·27 claims
- 4967US6733991B1AGS proteins and nucleic acid molecules and uses thereforOSI PHARM INC·Filed 2000·Granted May 11, 2004·1 cites·13 claims
- 5065US6689381B2Liposomal benzoquinazoline thymidylate synthase inhibitor formulationsOSI PHARM INC·Filed 2001·Granted Feb 10, 2004·4 cites·67 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →